January 14th - Kunming Pharmaceutical GroupIn response to investor inquiries on the interactive platform, the company stated that Xuesaitong soft capsules are its exclusive core dosage form. As a liquid dosage form, soft capsules offer faster absorption rates, and the simplified formulation and single excipient composition help optimize product safety from the source, creating a differentiated advantage. The company continues to explore the application of Xuesaitong soft capsules in precise indications and in combination with other drugs. Among these, the core product "Lixuwang" Xuesaitong soft capsules combined with aspirin in the integrated traditional Chinese and Western medicine treatment plan "Ali Therapy" has achieved good academic results. Simultaneously, leveraging its comprehensive R&D pipeline and technological reserves, the company continuously iterates and upgrades existing products to meet the medication needs of different patient groups and consolidate and enhance its long-term competitiveness. Furthermore, the company highly values the medication experience and needs of different patient groups and also offers Xuesaitong granules and Xuesaitong dripping pills as alternatives. Please use these medications as directed by your doctor.

网址：https://finance.eastmoney.com/a/202601143619196339.html